Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicament for treating neurasthenia

A neurasthenia and drug technology, applied in drug combinations, nervous system diseases, pharmaceutical formulations, etc., can solve the problems of unable to fundamentally cure neurasthenia patients, unable to improve cerebral vascular tone, and improve brain cell function, etc., to achieve recovery Brain cell function, increase cerebral blood flow supply, and improve the effect of tension

Inactive Publication Date: 2010-09-15
尹秉安
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, drugs such as oryzanol and deer antler tablets are often taken for the treatment of neurasthenia. The above-mentioned drugs only have a certain regulatory effect on patients with neurasthenia, can stabilize emotions, relieve anxiety and tension, but cannot dilate cerebral blood vessels and cannot improve cerebral blood vessels. Tension and improving brain cell function cannot fundamentally cure neurasthenia patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0006] A medicine for treating neurasthenia according to the invention, the composition and content of the medicine are: vitamin B 1 12 mg, B vitamins 6 10 mg, 9 mg of rutin, 10 mg of dimethazole, and 4 mg of chlordiazepoxide were mixed and packed into capsules; the patient took 2 capsules three times a day, two weeks as a course of treatment. After taking one course of treatment, patients generally feel dizziness, drowsiness, fatigue, irritability, insomnia, dreaminess, morning fatigue and other symptoms are significantly relieved; after taking two courses of treatment, the patient's symptoms and signs are significantly turned negative at the same time; Basically recover from illness, the cure rate reaches 99.5%.

[0007] Vitamin B in the above-mentioned drugs 1 and vitamin B 6 It has the effect of nourishing the central nervous system; rutin and dimethazole have the effect of selectively expanding cerebral blood vessels to increase cerebral blood flow, improve cerebral ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating neurasthenia, which consists of vitamin B1, vitamin B6, rutin, dibazol and chlordiazepoxide, and is loaded into capsules after the mixing; a patient orally takes 2 particles for three times every day, and two weeks are a treatment course. The medicine has functions of dilating cerebral vessels, increasing the supply of cerebral blood flow, strengthening the aerobic metabolism of brain cells, improving the tensity of the cerebral vessels, and restoring functions of the brain cells, thereby improving and curing dizziness, headache, drowsiness, dreaminess or insomnia, anxiety, amnesia, abnormal sensation, endocrine dyscrasia, sequela of cerebrovascular disease and the like, of patients, and radically curing neurasthenia patients. The medicine can also treat intestinal, gastric and cardiac neurosis, angioneurotic headache, climacteric syndrome, cerebral thrombosis or cerebral hemorrhage and cerebral trauma rehabilitation, moyamoya disease and the like.

Description

1. Technical field [0001] The invention relates to a medicine for treating human diseases, specifically a medicine for treating neurasthenia. 2. Background technology [0002] Neurasthenia is due to the long-term irregular state of excitation and inhibition of the human cerebral cortex, causing cerebral vasospasm, decreased cerebral blood flow, insufficient oxygen supply to the brain, and decreased brain cell function. It is characterized by dizziness, drowsiness, fatigue, and drowsiness in the daytime, and insomnia and dreaminess at night, and the normal person's excitation and inhibition time rules are lost. At present, drugs such as oryzanol and deer antler tablets are often taken for the treatment of neurasthenia. The above-mentioned drugs only have a certain regulatory effect on patients with neurasthenia, can stabilize emotions, relieve anxiety and tension, but cannot dilate cerebral blood vessels and cannot improve cerebral blood vessels. Tension and improving brain ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/51A61K31/4415A61K31/7048A61K31/4184A61K31/5513A61P25/00
Inventor 尹秉安尹隽
Owner 尹秉安
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com